Travel Medicine and Infectious Disease (May 2024)

Serological evidence of louse-borne relapsing fever in northern Kenya

  • Flavia Reyer,
  • Martyna Olesiuk,
  • Florian Röttgerding,
  • Volker Fingerle,
  • Abdulrahman Adamu,
  • Dan Waithiru,
  • John Njeru,
  • Peter Kraiczy

Journal volume & issue
Vol. 59
p. 102714

Abstract

Read online

Background: Tick- and louse-borne relapsing fever are highly-neglected, vector-borne diseases caused by diverse Borrelia species. Presently, there are no data available on the endemicity of tick- and louse-borne relapsing fever spirochetes in Kenya. Here, we present data of a retrospective study on the seroprevalence of louse-borne relapsing fever (LBRF) in northern Kenya. Methods: A novel immunoassay, recently established for the diagnosis of LBRF was utilized to screen 2005 blood samples collected from individuals with fever without a source in Turkana County, Kenya between May 2009 and November 2010 for anti-LBRF antibodies. Results: Out of the 2005 sera analyzed, 287 samples (14.3 %) were considered anti-LBRF IgG positive. Subsequent analyses revealed that 87 out of 152 sera randomly selected from these 2005 samples were tested positive (57.2 %) for anti-LBRF IgM antibodies. Most of the IgG and IgM positive samples were from individuals living in northern regions of Turkana County. Conclusion: Our serological finding provides strong evidence for the occurrence of LBRF in Kenya.

Keywords